LBA39 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neckJean Bourhis, Yunxia Tao, Clément Sire et al.|Annals of Oncology|2020Cited by 7
Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC studyJean Bourhis, Y. Tao, Xinghua Sun et al.|Annals of Oncology|2019Cited by 4